How to Analyse a Fertilizer Stock (Subsidy, Mix)

At the end of March 2026, Coromandel International was owed ₹2,168 crore by the Government of India — its fertilizer subsidy outstanding, up from ₹1,654 crore a year earlier (Coromandel Q4 FY26 concall). Across the full year it collected ₹10,649 crore of subsidy claims (Coromandel Q4 FY26 concall). Sit with those two numbers. Roughly 85% of the company's revenue for the year came through the subsidy channel (Coromandel Q4 FY26 concall) — which means the single largest customer of most Indian fertilizer makers is not a farmer at all. It is the government, and the government pays late. (Illustration of how to read the numbers, not a view on the stock.)

That fact reorganises everything you thought you knew about reading the business. A fertilizer company sells a bag of urea or NPK to a farmer at a Maximum Retail Price the government caps, then claims the difference between its cost and that capped price back from the state as subsidy. The reported profit looks like a manufacturing margin. The balance sheet tells you it is really a receivables-financing operation wrapped around a chemical plant — and whether the company makes money for you depends less on the fertilizer margin in any quarter and more on how big that government IOU grows, how it is funded, and whether the company has built anything that earns outside the subsidy net.

This is how to analyse a fertilizer stock the way a sector analyst does: the mix between price-controlled urea and freer NPK, the subsidy receivable that quietly runs the working capital, the gas cost that decides the urea margin, EBITDA per tonne, the non-subsidy crop-protection engine that re-rates the whole business, and the one variable nobody controls — the monsoon.

A boundary first: you cannot forecast the rains, and neither can management. What you can do is read whether a company is built to survive a weak monsoon and a subsidy delay, and whether it is slowly earning its way out of dependence on both.

What actually drives the economics of a fertilizer company?

Picture a shopkeeper forced by law to sell a sack of grain at a fixed price, well below what it cost him, on the government's commitment to reimburse the gap later — sometimes months later. He still has to pay his flour mill, his staff and his bank on time. The longer the government takes to settle, the more he borrows just to keep the shelves stocked. His "profit margin" can look fine while his bank balance bleeds. That is the Indian fertilizer business, and three forces fall out of it.

Price is administered, so the lever is volume and cost, not pricing. Urea's MRP is set by the government and barely moves; NPK and DAP ("complex" fertilizers) run on a Nutrient Based Subsidy where the subsidy per nutrient is fixed and the company carries the rest. A fertilizer maker cannot raise prices to defend a margin the way a paint company can. It defends margin by selling more tonnes, running its plant efficiently, and managing input cost — and by escaping into products the government doesn't price-control at all.

The subsidy receivable is the real working-capital story. Because the state pays in arrears, a fertilizer balance sheet is dominated by subsidy receivable and the inventory and debt needed to bridge it. A good year with a slow-paying government can swallow cash even as the P&L smiles. This is why two fertilizer companies with the same operating margin can have wildly different returns on capital.

Gas is the urea margin, and the monsoon is the volume. For urea makers, natural gas is the dominant cost, dollar-priced and imported at the margin; for everyone, the southwest monsoon decides how many bags farmers actually buy. Get the rains and the gas price wrong and the cleverest cost programme won't save the quarter.

Hold those three — administered price, subsidy receivable, gas-and-monsoon — and the metrics below stop being a list and become one story.

The metrics that matter — and where they hide

The uncomfortable part for anyone used to a clean P&L: the numbers that decide a fertilizer investment are mostly not on the income statement. The product mix, EBITDA per tonne, the subsidy outstanding, the gas cost, the non-subsidy share — these live in the investor presentation and the concall, and you have to go and get them. The income statement gives you sales and a blended operating margin that averages two completely different businesses into one misleading number.

Urea vs complex (NPK/DAP) mix

The first split to make. Urea is the most price-controlled, lowest-margin, most volume-stable product; complex fertilizers (NPK, DAP) carry the Nutrient Based Subsidy and swing more with input costs and farmer affordability. Why it matters here: the two earn nothing alike, and a blended margin hides which engine is running. Look at Chambal Fertilisers, which makes both: in Q3 FY26 its urea segment earned an EBIT margin of 17.28%, while its complex-fertilizer segment earned just 1.4% (Chambal Q3 FY26 concall). Same company, same quarter, a 12x gap. Where it hides: segment EBIT in the deck, never on the face of the P&L. A complex margin near 1% is the tell that subsidy and raw-material costs squeezed that book — read the two segments separately, always.

EBITDA per tonne (the manufactured margin)

The cleanest single measure of how profitable each tonne of fertilizer actually is, stripped of volume and trading noise — the sector's equivalent of NIM for a lender. Why it matters here: management runs the business to a "normative" per-tonne margin, so tracking the print against the norm tells you whether the core is healthy. Coromandel targets a normative manufactured EBITDA of about ₹5,000 per metric tonne (Coromandel Q1 FY26 concall) and, on its phos-acid backward integration, guided lifting the plant's average toward ₹6,500 a tonne (Coromandel Q3 FY26 concall). Where it hides: quoted on the call, occasionally in the deck. Read it across six to eight quarters — a single quarter tells you where the season and the raw-material cycle are, not where the company is.

Subsidy receivable and working-capital days

The metric that separates a reported profit from cash in the bank. Why it matters here: the government is the slow-paying mega-customer, so the size and ageing of the subsidy outstanding decides how much the company must borrow to keep operating. Chambal closed December 2025 with total receivables of ₹2,346 crore, of which ₹1,979 crore was subsidy owed by the state and only ₹367 crore was market debtors (Chambal Q3 FY26 concall) — the government dwarfs every private customer combined. Coromandel's debtor days jumped from 19 to 49 over FY26, lifting working-capital days to 57 (Screener.in, FY26) — a real cash effect that the rising headline didn't show. Where it hides: the subsidy figure is given on the call; the days appear when you compute them or read the ratios page. Watch the change: a receivable that grows faster than sales is the business funding the government on its balance sheet.

Gas cost (the urea margin)

For urea, natural gas is the single biggest cost, and it is dollar-linked. Why it matters here: under the gas-pooling and energy-norm system a plant's profitability turns on its energy efficiency against the norm; the gas price itself flows through to subsidy, but inefficiency does not — it is the company's to eat. Chambal's gas cost was $14.6 per MMBTU on an NCV basis in Q3 FY26 (Chambal Q3 FY26 concall). GNFC flagged roughly ₹13 crore of energy under-recovery in fertilizer in a single quarter (GNFC Q1 FY26 concall) — the cost of running above the energy norm. Where it hides: asked as a "bookkeeping question" on the call, almost never in the results. For a urea-heavy maker, energy efficiency versus the norm is the whole game; pair this read with how to analyse a city gas distribution company to see the gas chain from the other side.

Non-subsidy mix (crop protection and specialty)

The share of the business that earns outside the government's price control — agrochemicals, specialty nutrients, nano fertilizers. Why it matters here: this is the only part of a fertilizer company that can be re-rated like a normal business, because its margin isn't capped and its cash isn't held hostage by a subsidy cycle. It is the structural escape hatch. Coromandel's combined crop-protection revenue reached about ₹4,000 crore in FY26 with an EBITDA margin near 19% (Coromandel Q4 FY26 concall), and management is pushing the domestic formulation book to "grow aggressively by another 20%–25%" with six new launches (Coromandel Q4 FY26 concall). Chambal is building the same hedge, targeting ₹1,500 crore of crop-protection and specialty-nutrient revenue in FY26 (Chambal Q1 FY26 concall) at EBIT margins north of 22% (Chambal Q3 FY26 concall) — versus that 1.4% in complex fertilizer. Where it hides: segment revenue and margin in the deck. A rising non-subsidy share is the single most important structural improvement a fertilizer company can make; for the chemistry that powers it, see how to analyse a specialty chemicals company.

Capacity utilisation and net debt

The survival pair. Utilisation tells you whether expensive plant is earning; net debt tells you whether the subsidy bridge has been funded sensibly. Why it matters here: a fertilizer expansion is funded with borrowing, and the down-leg — a weak monsoon plus a slow subsidy — is when leverage bites. Deepak Fertilisers carried net debt of about ₹3,402 crore in Q2 FY26 at a net-debt-to-EBITDA around 2.27x by Q3 (Deepak Q2 and Q3 FY26 concalls), having brought the ratio down from 1.72x as new projects ramped (Deepak Q4 FY25 concall). Where it hides: net debt in the deck, the ratio on the call. Judge it against a weak-monsoon EBITDA, not a good year's.

How do you value a fertilizer stock?

Most of the sector trades on P/E, and for a fertilizer company that is defensible — earnings are nowhere near as violently cyclical as steel — but the P/E you should pay depends entirely on what kind of fertilizer company you are looking at, and the market knows it.

Compare two real multiples. Chambal Fertilisers, still majority urea-and-complex, trades at a P/E of about 9.6x with an ROCE of 25.5% (Screener.in, FY26). Coromandel, with its large and growing non-subsidy crop-protection and specialty book, trades at about 29.1x with a similar ROCE of 22.8% (Screener.in, FY26). Near-identical returns on capital, a 3x gap in the multiple. The market is not paying for the fertilizer margin; it is paying for the escape from it. A business that earns a rising share of profit outside the subsidy cage, with cash that isn't trapped in a government receivable, gets the consumer-chemistry multiple. A pure subsidy utility gets the utility multiple. Ranged across that spectrum sit the other listed makers — from urea-and-complex public-sector names like RCF, GSFC and FACT to an NPK-led player like Paradeep Phosphates — each priced for how far it has earned its way out of the subsidy core.

So the valuation question is not "what P/E does the sector deserve?" It is two questions. First: how much of this company's earnings comes from the price-controlled, government-financed core versus the freely-priced non-subsidy book — and which way is that mix moving? Second: how much cash is actually being generated, after the subsidy receivable is funded — because a 25% ROCE on paper means less if a growing slice of capital is permanently locked up lending to the state. A fertilizer maker that converts its profit to cash and is shifting toward non-subsidy earnings can carry a far higher multiple than one whose returns sit on the government's payment schedule.

The owner's frame: don't ask "is this cheap on this year's EPS?" Ask "how much of this profit is durable, free-priced and cash-backed — and what am I paying for that part?"

A worked case: Coromandel and the margin that didn't hold

The cleanest way to feel why one quarter never settles a fertilizer thesis is Coromandel's own normative-margin guidance through FY26 — set, reaffirmed, then quietly undershot when the season turned. (Illustration, not a view on the stock; figures as reported by the company.)

Through the first half, management was confident. In Q1 FY26 it told analysts the "normative EBITDA per metric ton of INR 5,000 will sustain during this year" (Coromandel Q1 FY26 concall); in Q2 it doubled down — "we target minimum INR 5,500 EBITDA per metric ton, which we are confident of doing it in the second half as well" (Coromandel Q2 FY26 concall). The volume backdrop looked supportive: NPK primary sales had run strong and consumption market share sat in the mid-teens (Coromandel concalls). Then the rabi season disappointed. By the Q4 call the same executive conceded the full year landed "around INR 5,000 plus" but that "fourth quarter was compressed; it was less than INR 3,500 for fourth quarter" (Coromandel Q4 FY26 concall) — a near-30% miss against the H2 confidence, driven by a muted rabi demand the company itself tied to the "late withdrawal of monsoon" (Coromandel Q4 FY26 concall).

Read the same record for what simply went quiet. At the start of FY25 management guided doubling its retail-store network to "1,500 plus by FY27" (Coromandel Q3 FY25 concall); by FY26 that target had dropped out of the commentary — guidance that quietly went silent. The point is not that anyone misled investors; this is, on the record, a well-run company whose non-subsidy engine kept compounding even as the fertilizer margin slipped. The point is the texture: a per-tonne margin reaffirmed with confidence and then compressed by a monsoon nobody controls, a store target dropped without remark, all inside the same fiscal year. You only see that pattern by tracking each commitment against the quarter it was made — the job of Promise Tracker, and the kind of thing nobody reconstructs by re-reading four transcripts by hand.

Red flags specific to a fertilizer company

• A blended margin you can't decompose. If you can't split urea from complex from non-subsidy, you don't know which engine is running. A flat overall margin can hide a complex book earning ~1% (Chambal Q3 FY26 concall) propped up by something else.
• Subsidy receivable growing faster than sales. The company is funding the government on its balance sheet; reported profit and cash are diverging. Always read the receivable change, not just the P&L.
• Working-capital days creeping up. Coromandel's debtor days nearly tripled to 49 in FY26 (Screener.in, FY26) — a real cash drag the headline profit didn't show.
• Net debt judged against a good monsoon. A leverage ratio that looks fine after strong rains can balloon after a weak kharif and a delayed subsidy. Stress it against a bad year.
• A high multiple with no non-subsidy escape. Paying a consumer multiple for a pure subsidy utility is paying for a re-rating that the business model can't deliver.
• Energy inefficiency in urea. Running above the energy norm is an under-recovery the company eats — GNFC's ~₹13 crore quarterly hit (GNFC Q1 FY26 concall) is the kind of leak that compounds.

Frequently asked questions

A repeatable workflow

1. Split the business. Urea vs complex vs non-subsidy — read three segments, never one blended margin.
2. Size the government IOU. Subsidy receivable, its ageing, and working-capital days, tracked as a change against sales.
3. Read EBITDA per tonne over time. Six to eight quarters from the deck against the company's own normative number.
4. Check the urea cost lever. Gas cost and energy efficiency versus the norm — the under-recoveries hide here.
5. Weigh the escape hatch. Non-subsidy revenue share and margin, and whether the mix is genuinely shifting.
6. Value the durable part. Pay the higher multiple only for cash-backed, free-priced earnings — and audit the guidance against what the monsoon actually allowed.

Inve's KPI Screener lines up EBITDA per tonne, subsidy outstanding, segment margins and non-subsidy mix across fertilizer companies — value, trend and a data-confidence flag per number — so the deck-and-concall hunt takes minutes, not an afternoon of PDF-mining. For a sibling story where the gap is a commodity spread and the P/E lies, read how to analyse a steel company.

Where this lens can be wrong. The strongest case against everything above is that fertilizer demand is genuinely defensive — India will keep feeding itself, urea volumes barely move year to year, and the subsidy, however slow, has always eventually been paid. On that view the receivable is a timing nuisance, not a risk, and a buyer of a cheap urea-heavy maker on 9–10x earnings is being paid handsomely to wait while the market over-discounts a payment delay that always clears. That case is coherent, and it has been right for long stretches. What it understates is the reinvestment problem: capital permanently tied up funding the government earns no compounding, so a high paper ROCE can mask poor cash-on-cash returns for years; and a policy regime that can be revised — subsidy rates up or down, energy norms tightened — is a risk no balance-sheet read fully captures. The honest claim is narrower than it looks: reading the mix, the receivable and the gas lever lowers your odds of mistaking a subsidy utility for a compounder, and raises your odds of spotting the company quietly earning its way out of the cage. It does not make the monsoon predictable, and it cannot tell you when Delhi will next change the rules.

The owner's question to sit with before buying any fertilizer stock: over a full cycle of monsoons and subsidy revisions — not this season's margin — how much of this company's profit is free-priced, cash-backed and growing, and how much is just a low-margin bag of urea sold on the government's credit? If the thesis leans on the subsidy core re-rating, you have bought the cage, not the bird that's trying to leave it.

Related reading

• How to Analyse a Bank Stock (NIM, CASA, GNPA, ROA)
• How to Analyse a Building Products Company (Pipes, Tiles)
• How to Analyse a Cables and Wires Stock